Differential immunotoxic effects of ethanol on murine EL-4 lymphoma and normal lymphocytes is mediated through increased ROS production and activation of p38MAPK

References

• Thanvi, B.R., Lo, T.C. Update on myasthenia gravis. Postgrad Med J 2004, 80, 690–700.
   PubMed Web of Science ®Google Scholar
• Wang, P., Zuo, C., Tian, J., Qian, Z., Ren, F., Shao, C., Wang, M., Lu, T. CT-guided percutaneous ethanol injection of the thymus for treatment of myasthenia gravis. AJR Am J Roentgenol 2003, 181, 721–724.
   PubMedGoogle Scholar
• Morton, L.M., Zheng, T., Holford, T.R., Holly, E.A., Chiu, B.C., Costantini, A.S., Stagnaro, E., Willett, E.V., Dal Maso, L., Serraino, D., Chang, E.T., Cozen, W., Davis, S., Severson, R.K., Bernstein, L., Mayne, S.T., Dee, F.R., Cerhan, J.R., Hartge, P.; InterLymph Consortium. Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis. Lancet Oncol 2005, 6, 469–476.
   PubMed Web of Science ®Google Scholar
• Lim, U., Morton, L.M., Subar, A.F., Baris, D., Stolzenberg-Solomon, R., Leitzmann, M., Kipnis, V., Mouw, T., Carroll, L., Schatzkin, A., Hartge, P. Alcohol, smoking, and body size in relation to incident Hodgkin’s and non-Hodgkin’s lymphoma risk. Am J Epidemiol 2007, 166, 697–708.
   PubMed Web of Science ®Google Scholar
• Patrick, R., Hagner, K. M., Bojie, D., Sharon, C., Zhao, F., Ronald, G. B. Alcohol consumption and decreased risk of non- Hodgkin lymphoma: role of mTOR dysfunction. Blood 2009, 113, 5526–5535.
   PubMedGoogle Scholar
• Redvanly, R.D., Chezmar, J.L., Strauss, R.M., Galloway, J.R., Boyer, T.D., Bernardino, M.E. Malignant hepatic tumors: safety of high-dose percutaneous ethanol ablation therapy. Radiology 1993, 188, 283–285.
   PubMedGoogle Scholar
• Kasagi, N. Ethanol induces apoptosis in human gastric carcinoma cells: The role of apoptosis related molecules. Yonago Acta Medica 1999, 42, 113–124.
   Google Scholar
• Kai, X., Li, J., Huang, S., Bai, Z. Apoptosis induced by low concentration ethanol in hepatocellular carcinoma cell strain and down-regulated AFP and surviving analysis by proteomic technology. Int J Biol Sci 2010, 6, 14–20.
   Google Scholar
• Slukvin, I.I., Jerrells, T.R. Different pathways of in vitro ethanol-induced apoptosis in thymocytes and splenic T and B lymphocytes. Immunopharmacology 1995, 31, 43–57.
   PubMedGoogle Scholar
• Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65, 55–63.
   PubMed Web of Science ®Google Scholar
• Khan, N.M., Sandur, S.K., Checker, R., Sharma, D., Poduval, T.B., Sainis, K.B. Pro-oxidants ameliorate radiation-induced apoptosis through activation of the calcium-ERK1/2-Nrf2 pathway. Free Radic Biol Med 2011, 51, 115–128.
   PubMed Web of Science ®Google Scholar
• Wilankar, C., Khan, N.M., Checker, R., Sharma, D., Patwardhan, R., Gota, V., Sandur, S.K., Devasagayam, T.P. ?-Tocotrienol Induces Apoptosis in Human T Cell Lymphoma through Activation of Both Intrinsic and Extrinsic Pathways. Curr Pharm Des 2011, 17, 2176–2189.
   PubMed Web of Science ®Google Scholar
• Khan, N.M., Poduval, T.B. Immunomodulatory and immunotoxic effects of bilirubin: molecular mechanisms. J Leukoc Biol 2011, 90, 997–1015.
   PubMed Web of Science ®Google Scholar
• Nagasawa, M., Iino, Y., Yokoe, T., Takei, H., Maemura, M., Horiguchi, J., Horii, Y., Matumato, H., Morishita, Y. Percutaneous ethanol injection therapy for patient with inoperable thyroid papillary cancer: a report of two cases. Int J Clin Oncol 2000, 5, 284–287.
   Google Scholar
• Castaneda, F., Kinne, R.K. Ethanol treatment of hepatocellular carcinoma: high potentials of low concentrations. Cancer Biol Ther 2004, 3, 430–433.
   PubMed Web of Science ®Google Scholar
• Vallone, P., Catalano, O., Izzo, F., Siani, A. Combined ethanol injection therapy and radiofrequency ablation therapy in percutaneous treatment of hepatocellular carcinoma larger than 4 cm. Cardiovasc Intervent Radiol 2006, 29, 544–551.
   PubMed Web of Science ®Google Scholar
• Jansena, M. C., Hillegersbergb, R. V., Chamuleauc, R. A. F. M., Deldend, O. M. V., Goumaa, D. J., Gulika, T. M. V. Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review. Eur J Surg Onc 2005, 31, 331–347.
   PubMedGoogle Scholar
• Lee, M.J., Mueller, P.R., Dawson, S.L., Gazelle, S.G., Hahn, P.F., Goldberg, M.A., Boland, G.W. Percutaneous ethanol injection for the treatment of hepatic tumors: indications, mechanism of action, technique, and efficacy. AJR Am J Roentgenol 1995, 164, 215–220.
   PubMed Web of Science ®Google Scholar
• Castaneda, F., Rosin-Steiner, S. Low concentration of ethanol induce apoptosis in HepG2 cells: role of various signal transduction pathways. Int J Med Sci 2006, 3, 160–167.
   PubMedGoogle Scholar
• Silberman, S., McGarvey, T.W., Comrie, E., Persky, B. The influence of ethanol on cell membrane fluidity, migration, and invasion of murine melanoma cells. Exp Cell Res 1990, 189, 64–68.
   PubMedGoogle Scholar
• Chan, W.H., Chang, Y.J. Dosage effects of resveratrol on ethanol-induced cell death in the human K562 cell line. Toxicol Lett 2006, 161, 1–9.
   PubMedGoogle Scholar
• Higuchi, H., Kurose, I., Kato, S., Miura, S., Ishii, H. Ethanol-induced apoptosis and oxidative stress in hepatocytes. Alcohol Clin Exp Res 1996, 20, 340A–346A.
   Google Scholar
• Cardin, R., D’Errico, A., Fiorentino, M., Cecchetto, A., Naccarato, R., Farinati, F. Hepatocyte proliferation and apoptosis in relation to oxidative damage in alcohol-related liver disease. Alcohol Alcohol 2002, 37, 43–48.
   PubMedGoogle Scholar
• Kasdallah-Grissa, A., Mornagui, B., Aouani, E., Hammami, M., Gharbi, N., Kamoun, A., El-Fazaa, S. Protective effect of resveratrol on ethanol-induced lipid peroxidation in rats. Alcohol Alcohol 2006, 41, 236–239.
   PubMed Web of Science ®Google Scholar
• Nakayama, N., Eichhorst, S.T., Müller, M., Krammer, P.H. Ethanol-induced apoptosis in hepatoma cells proceeds via intracellular Ca(2+) elevation, activation of TLCK-sensitive proteases, and cytochrome c release. Exp Cell Res 2001, 269, 202–213.
   PubMed Web of Science ®Google Scholar
• Schumacker, P.T. Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell 2006, 10, 175–176.
   PubMed Web of Science ®Google Scholar
• Buytaert, E., Dewaele, M., Agostinis, P. Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. Biochim Biophys Acta 2007, 1776, 86–107.
   PubMed Web of Science ®Google Scholar
• Wang, C.C., Chiang, Y.M., Sung, S.C., Hsu, Y.L., Chang, J.K., Kuo, P.L. Plumbagin induces cell cycle arrest and apoptosis through reactive oxygen species/c-Jun N-terminal kinase pathways in human melanoma A375.S2 cells. Cancer Lett 2008, 259, 82–98.
   PubMed Web of Science ®Google Scholar
• Hsu, S.C., Gavrilin, M.A., Tsai, M.H., Han, J., Lai, M.Z. p38 mitogen-activated protein kinase is involved in Fas ligand expression. J Biol Chem 1999, 274, 25769–25776.
   PubMedGoogle Scholar
• Laethem, A. V., Sofie, V. K., Saskia, L., Wim, D., Peter, V., Stefan, J., Jackie, R. V., Maria, G., Patrizia, A. Activation of p38 MAPK is required for Bax translocation to mitochondria, cytochrome c release and apoptosis induced by UVB irradiation in human keratinocytes. FASEB J 2004, 18, 1946–1948.
   PubMedGoogle Scholar
• Prieto, R., Sanchez, J. M. R., Yoichi, T., Gutkind, J. S. A Role for the p38 mitogen-activated protein kinase pathway in the transcriptional activation of p53on genotoxic stress by chemotherapeutic agents. Cancer Res 2000, 60, 2464–2472.
   PubMedGoogle Scholar
• Connor, L. O. Fas, p53, and apoptosis. Science 1999, 284, 1431.
   Google Scholar
• Feng, Z., Zhang, H., Levine, A.J., Jin, S. The coordinate regulation of the p53 and mTOR pathways in cells. Proc Natl Acad Sci USA 2005, 102, 8204–8209.
   PubMed Web of Science ®Google Scholar
• Budanov, A.V., Karin, M. p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell 2008, 134, 451–460.
   PubMed Web of Science ®Google Scholar